News
TFX
137.71
-0.74%
-1.03
Teleflex (TFX) Is Up 6.3% After OEM Sale And 2026 EPS Upgrade - What's Changed
Simply Wall St · 1d ago
Nvidia To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 3d ago
Teleflex Is Maintained at Buy by Needham
Dow Jones · 3d ago
Teleflex Price Target Raised to $170.00/Share From $159.00 by Needham
Dow Jones · 3d ago
Needham Maintains Buy on Teleflex, Raises Price Target to $170
Benzinga · 3d ago
Teleflex Initiated With Buy as Freesolve Platform Drives Long-Term Growth; Price Target Raised from $159 to $170
TipRanks · 3d ago
Weekly Report: what happened at TFX last week (0817-0821)?
Weekly Report · 4d ago
Teleflex Earnings Call: EPS Up, Integration Weighs
TipRanks · 4d ago
Teleflex: Strong Company Undergoing Messy Transition, Hold
Seeking Alpha · 5d ago
Teleflex: Portfolio Surgery Creates A Better Medtech Compounder
Seeking Alpha · 5d ago
Invesco Small Cap Value Fund Q2 2026 Portfolio Activity
Seeking Alpha · 08/20 16:25
Teleflex (TFX) Trimmed Its Earnings Outlook, Is The Stock Still A Bargain?
Simply Wall St · 08/20 12:29
Weekly Report: what happened at TFX last week (0810-0814)?
Weekly Report · 08/17 10:28
Will Teleflex’s (TFX) Lowered 2026 Earnings Guidance and Margin Pressures Redefine Its Portfolio Story?
Simply Wall St · 08/17 05:23
Teleflex (TFX) Completed A $1.5 Billion OEM Divestiture
Simply Wall St · 08/15 07:23
Seth Klarman's Baupost adds Pershing Square in Q2; boosts Amazon, Alphabet
Seeking Alpha · 08/13 21:46
Teleflex Is Maintained at Neutral by UBS
Dow Jones · 08/11 21:17
UBS Maintains Neutral on Teleflex, Raises Price Target to $158
Benzinga · 08/11 21:07
Teleflex price target raised to $158 from $145 at UBS
TipRanks · 08/11 12:50
Teleflex Is Maintained at Hold by Truist Securities
Dow Jones · 08/10 18:30
More
Webull provides a variety of real-time TFX stock news. You can receive the latest news about Teleflex Inc through multiple platforms. This information may help you make smarter investment decisions.
About TFX
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, and vascular access. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of the MANTA Vascular Closure device, Arrow OnControl powered bone biopsy system, GuideLiner, Turnpike and TrapLiner catheters.